• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[匈牙利及全球宫颈癌流行病学]

[Epidemiology of cervical cancer in Hungary and the world].

作者信息

Krasznai Zoárd, Molnár Szabolcs

机构信息

ÁOK, Debreceni Egyetem, Szülészeti és Nőgyógyászati Intézet, Debrecen, Hungary.

出版信息

Magy Onkol. 2022 Dec 31;66(4):262-269. Epub 2022 Dec 7.

PMID:36602245
Abstract

Cervical cancer is one of the most common cancers among women and one of those completely preventable according to the current state of medical science. The pathogenesis of the disease is known, the human papillomavirus plays an essential role in the development in 99.9% of cases. With the available vaccines against the virus and the use of effective screening methods, the complete elimination of the disease can be achieved within a few decades, according to WHO estimates. Despite all these facts, the current state of the fight against the disease is still very controversial, which can be characterized by the epidemiological indicators of the disease. We would like to present these data in our publication, highlighting the challenges that not only developing but also developed countries face every day in relation to the prevention of cervical cancer.

摘要

宫颈癌是女性中最常见的癌症之一,并且根据当前医学科学状况,是完全可预防的癌症之一。该疾病的发病机制已知,人乳头瘤病毒在99.9%的病例发展过程中起着至关重要的作用。根据世界卫生组织的估计,有了针对该病毒的可用疫苗以及有效的筛查方法,在几十年内就可以完全消除这种疾病。尽管有所有这些事实,但目前抗击该疾病的状况仍然非常具有争议性,这可以通过该疾病的流行病学指标来体现。我们希望在我们的出版物中呈现这些数据,突出发展中国家以及发达国家在预防宫颈癌方面每天都面临的挑战。

相似文献

1
[Epidemiology of cervical cancer in Hungary and the world].[匈牙利及全球宫颈癌流行病学]
Magy Onkol. 2022 Dec 31;66(4):262-269. Epub 2022 Dec 7.
2
Human papillomavirus vaccination and cervical cancer risk.人乳头瘤病毒疫苗接种与宫颈癌风险。
BMJ. 2022 Dec 15;379:e070115. doi: 10.1136/bmj-2022-070115.
3
Human papillomavirus vaccines: new tools for accelerating cervical cancer prevention in developing countries.人乳头瘤病毒疫苗:发展中国家加速宫颈癌预防的新工具。
Immunotherapy. 2009 Sep;1(5):795-807. doi: 10.2217/imt.09.48.
4
[In defence of women against HPV-infection].[保护女性免受人乳头瘤病毒感染]
Orv Hetil. 2007 Apr 29;148(17):813. doi: 10.1556/OH.2007.17B.
5
Cervical Cancer Prevention in Low- and Middle-Income Countries.中低收入国家的宫颈癌预防
Clin Obstet Gynecol. 2021 Sep 1;64(3):501-518. doi: 10.1097/GRF.0000000000000629.
6
Impact of HPV vaccination and cervical screening on cervical cancer elimination: a comparative modelling analysis in 78 low-income and lower-middle-income countries.HPV 疫苗接种和宫颈筛查对宫颈癌消除的影响:78 个低收入和中低收入国家的比较建模分析。
Lancet. 2020 Feb 22;395(10224):575-590. doi: 10.1016/S0140-6736(20)30068-4. Epub 2020 Jan 30.
7
Role of human papillomavirus (HPV) in cancers.人乳头瘤病毒(HPV)在癌症中的作用。
S Afr Med J. 2023 Oct 23;113(10):10. doi: 10.7196/SAMJ.2023.v113i10.1318.
8
Human papillomavirus vaccines versus cervical cancer screening.人乳头瘤病毒疫苗与宫颈癌筛查
Clin Oncol (R Coll Radiol). 2008 Aug;20(6):388-94. doi: 10.1016/j.clon.2008.04.006. Epub 2008 Jun 5.
9
The cost effectiveness of a quadrivalent human papillomavirus vaccine (6/11/16/18) in Hungary.匈牙利四价人乳头瘤病毒(6/11/16/18)疫苗的成本效益。
J Med Econ. 2010 Mar;13(1):110-8. doi: 10.3111/13696990903546013.
10
Comprehensive control of human papillomavirus infections and related diseases.人乳头瘤病毒感染及相关疾病的综合防控。
Vaccine. 2013 Dec 29;31 Suppl 5:F1-31. doi: 10.1016/j.vaccine.2013.10.001.

引用本文的文献

1
MRI-based image-guided adaptive brachytherapy for locally advanced cervical cancer in clinical routine: a single-institution experience.基于磁共振成像的图像引导自适应近距离放射治疗在局部晚期宫颈癌临床常规治疗中的应用:单机构经验
Pathol Oncol Res. 2025 May 1;31:1612077. doi: 10.3389/pore.2025.1612077. eCollection 2025.
2
Factors Associated With Cervical Cancer Screening Attendance in Hungary Based on the European Health Interview Survey.基于欧洲健康访谈调查,匈牙利宫颈癌筛查参与率的相关因素分析。
Int J Public Health. 2024 Aug 29;69:1607509. doi: 10.3389/ijph.2024.1607509. eCollection 2024.